DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630)...

In France, the new coronary drug eluting stent (DES) named Supraflex (Sahajanand Medical Technologies - SMT) will be reimbursed €630 from...